Company
Espervita Therapeutics
Giving hope to patients for a better life.
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Espervita Therapeutics is focused on the discovery of metabolic reprogramming therapies, with a lead program developing first-in-class acetyl-CoA metabolic enzyme inhibitors with beneficial effects across a range of metabolic disease conditions.
Products
- Other
- EVT0185
Loading relationship preview